Parkinson's Disease

Understanding Parkinson's Disease

Parkinson's disease results from the loss of dopamine-producing neurons in the substantia nigra, a region deep within the brain. This leads to the characteristic motor symptoms—tremor, rigidity, bradykinesia (slowness of movement), and postural instability—as well as non-motor symptoms including cognitive changes, mood disorders, and sleep problems.

Why TPS for Parkinson's Disease

TPS is an emerging neuromodulation approach being studied in neurological and neurodegenerative conditions. In Parkinson's disease, the research rationale includes investigation of deeper neural structures and networks; however, this should be distinguished from established clinical efficacy. TPS is not presented as proven to improve motor or non-motor Parkinson's symptoms. Any consideration of TPS should occur alongside established neurological care and individual clinical suitability assessment.

Our Treatment Approach

Our TPS programme for Parkinson's disease begins with comprehensive assessment including QEEG brain mapping to identify specific patterns of dysfunction. Treatment protocols are personalised based on individual symptoms and neurophysiological profiles.

The treatment process involves:

• Initial QEEG brain mapping to assess brain function
• Development of personalised TPS protocol targeting affected subcortical regions
• Regular treatment sessions using neuronavigation guidance
• Ongoing monitoring of both motor and non-motor symptoms
• Coordination with your existing Parkinson's care team

What to Expect

TPS treatment for Parkinson's disease is a non-invasive procedure. Sessions typically last varies and are well-tolerated. The number of sessions and treatment duration will be discussed during your consultation based on your specific symptoms and response.

TPS is designed to complement your existing Parkinson's care and treatment plan. We work alongside your neurologist and other healthcare providers to ensure coordinated, comprehensive care.